@arndtvogel.bsky.social discusses #ABC-HCC and #TALENTop studies and puts them into the context.
Positive studies, potential novel strategies, still open questions.
Key message, #MDT is key in the management of patients with #HCC.
#ESMO25 #ESMOAmbassadors @myesmo.bsky.social

Hui-Chuan Sun presents the #TALENTop phase 3 study of atezolizumab-bevacizumab followed by surgery in locally advanced #HCC.
Positive study, #MDT discussion is key!
#ESMO25 #ESMOAmbassadors @myesmo.bsky.social